Literature DB >> 18619657

Patterns of hematuria referral to urologists: does a gender disparity exist?

Emilie K Johnson1, Stephanie Daignault, Yingxi Zhang, Cheryl T Lee.   

Abstract

OBJECTIVES: To examine the referral patterns of hematuria within a nonprofit healthcare organization to determine the factors that influence referral. Hematuria continues to be an important sign of urologic disease, including urothelial malignancy. An increasing awareness of gender differences in tumor stage at bladder cancer presentation has led to speculation about delayed referral and diagnosis in women. However, little is known about the referral patterns of hematuria and whether gender differences exist.
METHODS: The insurance records were examined from 926 consecutive adult health plan participants (559 men and 367 women) with newly diagnosed hematuria from 1998 to 2002. The patterns of urologic referral were evaluated. A Cox multivariate regression model was used to examine the relationship between urologic referral and the relevant variables.
RESULTS: Overall, 263 men (47%) and 102 women (28%) were referred for urologic evaluation of hematuria, with a median follow-up of 27 and 26 months, respectively. Referral was initiated by the primary care physician in 80% of the cohort. Increased urologic referral was associated with advancing age, repeated hematuria, provider type, and male gender. The adjusted hazard ratio of male referral was 1.65 (95% confidence interval 1.31-2.08) compared with female referral.
CONCLUSIONS: Primary care physicians practicing in a managed care setting are less likely to refer women for a urologic evaluation of new or first recurrent episodes of hematuria than to refer men in all patient age categories, except for 40-49 years. This apparent gender disparity could result in unequal access of specialty evaluation and could potentially delay the diagnosis of important urologic conditions.

Entities:  

Mesh:

Year:  2008        PMID: 18619657     DOI: 10.1016/j.urology.2008.01.086

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  31 in total

1.  Is there a gender effect in bladder cancer? A population-based study of practice and outcomes.

Authors:  Francis Michael Patafio; D Robert Siemens; Xuejiao Wei; Christopher M Booth
Journal:  Can Urol Assoc J       Date:  2015 Jul-Aug       Impact factor: 1.862

Review 2.  Contemporary gender-specific outcomes in Germany after radical cystectomy for bladder cancer.

Authors:  Marianne Schmid; Shahrokh F Shariat; Armin Soave; Oliver Engel; Margit Fisch; Michael Rink
Journal:  Curr Urol Rep       Date:  2014-06       Impact factor: 3.092

3.  Gender-dependent cancer-specific survival following radical cystectomy.

Authors:  Matthias May; Christian Stief; Sabine Brookman-May; Wolfgang Otto; Christian Gilfrich; Jan Roigas; Mario Zacharias; Wolf F Wieland; Hans-Martin Fritsche; Ferdinand Hofstädter; Maximilian Burger
Journal:  World J Urol       Date:  2011-10-09       Impact factor: 4.226

4.  Geographic Variation in Cystoscopy Rates for Suspected Bladder Cancer between Female and Male Medicare Beneficiaries.

Authors:  David S Han; Weiping Zhou; John D Seigne; Kristine E Lynch; Florian R Schroeck
Journal:  Urology       Date:  2018-08-20       Impact factor: 2.649

5.  Urologist referral delay and its impact on survival after radical cystectomy for bladder cancer.

Authors:  F Santos; A Dragomir; W Kassouf; E Franco; A Aprikian
Journal:  Curr Oncol       Date:  2015-02       Impact factor: 3.677

6.  Immunocytology is a strong predictor of bladder cancer presence in patients with painless hematuria: a multicentre study.

Authors:  Eugene K Cha; Lenuta-Ancuta Tirsar; Christian Schwentner; Paul J Christos; Christine Mian; Joerg Hennenlotter; Thomas Martini; Arnulf Stenzl; Armin Pycha; Shahrokh F Shariat; Bernd J Schmitz-Dräger
Journal:  Eur Urol       Date:  2011-09-09       Impact factor: 20.096

Review 7.  Impact of gender on bladder cancer incidence, staging, and prognosis.

Authors:  Harun Fajkovic; Joshua A Halpern; Eugene K Cha; Atessa Bahadori; Thomas F Chromecki; Pierre I Karakiewicz; Eckart Breinl; Axel S Merseburger; Shahrokh F Shariat
Journal:  World J Urol       Date:  2011-06-09       Impact factor: 4.226

8.  Gender, race, and variation in the evaluation of microscopic hematuria among Medicare beneficiaries.

Authors:  Jeffrey C Bassett; JoAnn Alvarez; Tatsuki Koyama; Matthew Resnick; Chaochen You; Shenghua Ni; David F Penson; Daniel A Barocas
Journal:  J Gen Intern Med       Date:  2014-12-02       Impact factor: 5.128

9.  Variation in the intensity of hematuria evaluation: a target for primary care quality improvement.

Authors:  David F Friedlander; Matthew J Resnick; Chaochen You; Jeffrey Bassett; Vidhush Yarlagadda; David F Penson; Daniel A Barocas
Journal:  Am J Med       Date:  2014-01-28       Impact factor: 4.965

10.  A noninvasive multianalyte urine-based diagnostic assay for urothelial cancer of the bladder in the evaluation of hematuria.

Authors:  R Jeffrey Karnes; Cecilia A Fernandez; Anthony P Shuber
Journal:  Mayo Clin Proc       Date:  2012-08-09       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.